Dialogue Health Technologies (TSX:CARE) - Aktienkurs, Nachrichten und Analyse

CARE Aktienübersicht

Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada, the United Kingdom, Germany, and Internationally. Mehr Details

CARE grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	2/6
Künftiges Wachstum	4/6
Vergangene Leistung	0/6
Finanzielle Gesundheit	4/6
Dividenden	0/6

Belohnungen

84.7% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 119.22% pro Jahr

Die Erträge sind in den letzten 5 Jahren um 7.2% pro Jahr gestiegen.

Risikoanalyse

Bei unseren Risikoprüfungen wurden keine Risiken für CARE festgestellt.

Dialogue Health Technologies Inc. Wettbewerber

Viemed Healthcare

TSX:VMD

CA$311.8m

Healwell AI

TSX:AIDX

CA$232.9m

Quipt Home Medical

TSX:QIPT

CA$146.5m

WELL Health Technologies

TSX:WELL

CA$1.3b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Dialogue Health Technologies
Historische Aktienkurse
Aktueller Aktienkurs	CA$5.14
52-Wochen-Hoch	CA$5.16
52-Wochen-Tief	CA$2.05
Beta	2.78
11 Monat Veränderung	0.69%
3 Monate Veränderung	66.88%
1 Jahr Veränderung	106.43%
33 Jahre Veränderung	n/a
5 Jahre Veränderung	n/a
Veränderung seit IPO	-63.96%

Aktuelle Nachrichten und Updates

Recent updates

Dialogue Health Technologies Inc.'s (TSE:CARE) Intrinsic Value Is Potentially 90% Above Its Share Price

Mar 14

Dialogue Health Technologies Inc. (TSE:CARE) Just Reported Earnings, And Analysts Cut Their Target Price

Nov 17

An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 37% Undervalued

Jun 28

An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 48% Undervalued

Feb 11

Calculating The Fair Value Of Dialogue Health Technologies Inc. (TSE:CARE)

Nov 07

Aktionärsrenditen

	CARE	CA Healthcare	CA Markt
7D	0.2%	-0.8%	0.7%
1Y	106.4%	41.3%	21.7%

Rendite im Vergleich zur Industrie: CARE übertraf die Branche Canadian Healthcare , die im vergangenen Jahr eine Rendite von 41.3 erzielte.

Rendite vs. Markt: CARE übertraf den Markt Canadian, der im vergangenen Jahr eine Rendite von 21.7 erzielte.

Preisvolatilität

Is CARE's price volatile compared to industry and market?
CARE volatility
CARE Average Weekly Movement	12.0%
Healthcare Industry Average Movement	4.2%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	17.6%
10% least volatile stocks in CA Market	2.9%

Stabiler Aktienkurs: CAREDer Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.

Volatilität im Zeitverlauf: CAREDie wöchentliche Volatilität (12%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
2016	240	Cherif Habib	dialogue.co

Dialogue Health Technologies Inc.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Dialogue Health Technologies im Vergleich zum Marktanteil des Unternehmens?
CARE grundlegende Statistiken
Marktanteil	CA$345.99m
Gewinn(TTM)	-CA$19.50m
Umsatz(TTM)	CA$95.88m

3.6x

Kurs-Umsatz-Verhältnis

-17.8x

Kurs-Gewinn-Verhältnis

Ist CARE zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
CARE Gewinn- und Verlustrechnung (TTM)
Einnahmen	CA$95.88m
Kosten der Einnahmen	CA$41.84m
Bruttogewinn	CA$54.03m
Sonstige Ausgaben	CA$73.54m
Umsatz	-CA$19.50m

Zuletzt gemeldete Gewinne

Jun 30, 2023

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	-0.29
Bruttomarge	56.36%
Nettogewinnspanne	-20.34%
Schulden/Eigenkapital-Verhältnis	1.0%

Wie hat sich CARE auf lange Sicht entwickelt?

Historische Performance und Vergleiche

CARE Aktienübersicht

Belohnungen

Risikoanalyse

Dialogue Health Technologies Inc. Wettbewerber

TSX:VMD

CA$311.8m

TSX:AIDX

CA$232.9m

TSX:QIPT

CA$146.5m

TSX:WELL

CA$1.3b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Dialogue Health Technologies Inc. to Appoint Swati Matta as Head of Women's Health

Sun Life Assurance Company of Canada completed the acquisition of an additional 74.8% stake in Dialogue Health Technologies Inc. (TSX:CARE) from a group of shareholders.

Forecast breakeven date moved forward to 2024

Consensus EPS estimates fall by 22%

First quarter 2023 earnings released: CA$0.04 loss per share (vs CA$0.10 loss in 1Q 2022)

Forecast breakeven date moved forward to 2024

Recent updates

Dialogue Health Technologies Inc. to Appoint Swati Matta as Head of Women's Health

Sun Life Assurance Company of Canada completed the acquisition of an additional 74.8% stake in Dialogue Health Technologies Inc. (TSX:CARE) from a group of shareholders.

Forecast breakeven date moved forward to 2024

Consensus EPS estimates fall by 22%

First quarter 2023 earnings released: CA$0.04 loss per share (vs CA$0.10 loss in 1Q 2022)

Forecast breakeven date moved forward to 2024

Dialogue Health Technologies Inc. to Report Q2, 2023 Results on Aug 14, 2023

Sun Life Financial Inc. (TSX:SLF) entered into an agreement to acquire a 74.8% stake in Dialogue Health Technologies Inc. (TSX:CARE) from a group of shareholders for approximately CAD 270 million.

Sun Life Financial Inc. (TSX:SLF) entered into an agreement to acquire a 74.8% stake in Dialogue Health Technologies Inc. (TSX:CARE) from a group of shareholders for approximately CAD 270 million.

Dialogue Health Technologies Inc. Provides Revenue Guidance for the Second Quarter of 2023

Forecast to breakeven in 2025

First quarter 2023 earnings: EPS exceeds analyst expectations

Full year 2022 earnings: EPS in line with expectations, revenues disappoint

Dialogue Health Technologies Inc.'s (TSE:CARE) Intrinsic Value Is Potentially 90% Above Its Share Price

Dialogue Health Technologies Inc. Provides Earnings Guidance for the Three-Month Period Ending December 31, 2022

An unknown buyer entered into a definitive agreement to acquire Occupational Health Safety ("OHS") service in Germany from Dialogue Health Technologies Inc. (TSX:CARE).

Co-Founder exercised options to buy CA$250k worth of stock.

No longer forecast to breakeven

Dialogue Health Technologies Inc. (TSE:CARE) Just Reported Earnings, And Analysts Cut Their Target Price

Price target decreased to CA$5.03

Dialogue Health Technologies Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

High number of new directors

Dialogue Health Technologies Inc. to Report Q3, 2022 Results on Nov 14, 2022

Sterling Capital Brokers partners with Dialogue Health Technologies Inc. to Launch First-Ever Integrated Virtual Health Program

Dialogue Health Technologies Inc. Provides Earnings Outlook for the Third Quarter of 2022

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to CA$7.17

Dialogue Health Technologies Inc. to Report Q2, 2022 Results on Aug 10, 2022

An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 37% Undervalued

Now 25% undervalued after recent price drop

Independent Director exercised options to buy CA$62k worth of stock.

Dialogue Health Technologies Inc. Announces Executive Changes

Forecast to breakeven in 2024

Price target decreased to CA$9.17

First quarter 2022 earnings: EPS misses analyst expectations

High number of new directors

Dialogue Health Technologies Inc. Launches Mental Health+, Responding to Evolving Mental Health Challenges in Organizations

Dialogue Health Technologies Inc. (TSX:CARE) entered into an agreement to acquire Tictrac Limited for £35 million.

Consensus forecasts updated

Dialogue Health Technologies Inc. (TSX:CARE) entered into an agreement to acquire Tictrac Limited for £35 million.

Consensus EPS estimates fall by 10%

Dialogue Health Technologies Inc., Annual General Meeting, May 16, 2022

Dialogue Health Technologies Inc. to Report Q4, 2021 Results on Mar 23, 2022

An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 48% Undervalued

Sun Life Assurance Company of Canada acquired an additional 9.18% stake in Dialogue Health Technologies Inc. (TSX:CARE) for CAD 48.3 million.

Third quarter 2021 earnings released: CA$0.10 loss per share

Calculating The Fair Value Of Dialogue Health Technologies Inc. (TSE:CARE)

Co-Founder recently bought CA$70k worth of stock

Dialogue Health Technologies Inc. (TSX:CARE) acquired eHub Health Pty Limited.

Co-Founder & CEO recently bought CA$1.8m worth of stock

Aktionärsrenditen

Preisvolatilität

Über das Unternehmen

Dialogue Health Technologies Inc.'s Grundlagenzusammenfassung

3.6x

-17.8x

Erträge &amp; Einnahmen

Erträge & Einnahmen